The synthetic flavonoid WYC02-9 inhibits cervical cancer cell migration/invasion and angiogenesis via MAPK14 signaling

Gynecologic Oncology

Volumn 131, Issue 3, 2013, Pages 734-743

  Chen, Yun Ju ^a,b   Cheng, Yu Jen ^c,d   Hung, Amos C ^a,b   Wu, Yang Chang ^e,f   Hou, Ming Feng ^a,g   Tyan, Yu Chang ^h,i   Yuan, Shyng Shiou F ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c E DA HOSPITAL   (Taiwan)

^d I SHOU UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

^h KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

ⁱ NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; Cervical cancer; Invasion; Migration; Viability; WYC02 9

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AGAR; ANTINEOPLASTIC AGENT; CISPLATIN; FLAVONOID; GELATIN; GELATINASE A; GELATINASE B; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE 14; UNCLASSIFIED DRUG; WYC 02 9; WYC02 9;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL ASSAY; CELL CYCLE G2 PHASE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DESIGN; FEMALE; HUMAN; HUMAN CELL; IC 50; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; M PHASE CELL CYCLE CHECKPOINT; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSWELL INVASION ASSAY; UTERINE CERVIX CANCER; WOUND HEALING ASSAY; ZEBRA FISH; ZYMOGRAPHY;

ANGIOGENESIS; CERVICAL CANCER; INVASION; MIGRATION; VIABILITY; WYC02-9;

ANIMALS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL MOVEMENT; CYCLOHEXANONES; FEMALE; FLAVONES; FLAVONOIDS; HELA CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE 14; NEOVASCULARIZATION, PATHOLOGIC; UTERINE CERVICAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS; ZEBRAFISH;

EID: 84888298985     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.10.012     Document Type: Article

References (46)

1. T.C. Wright Jr., and L. Kuhn Alternative approaches to cervical cancer screening for developing countries Best Pract Res Clin Obstet Gynaecol 26 2012 197 208
2. V.T. Devita, S. Hellman, and S.A. Rosenberg Cancer: principles and practice of oncology 8th ed. 2007 Lippincott Williams & Wilkins Philadelphia, PA
3. A. González-Martín, L. González-Cortijo, N. Carballo, J.F. Garcia, F. Lapuente, and A. Rojo The current role of neoadjuvant chemotherapy in the management of cervical carcinoma Gynecol Oncol 110 2008 S36 S40
4. W.A. Peters III, P.Y. Liu, R.J. Barrett II, R.J. Stock, B.J. Monk, and J.S. Berek Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early stage cancer of the cervix J Clin Oncol 18 2000 1606 1613
5. I. Cadron, T. Van Gorp, F. Amant, K. Leunen, P. Neven, and I. Vergote Chemotherapy for recurrent cervical cancer Gynecol Oncol 107 2007 S113 S118
6. Z.H. Siddik Cisplatin: mode of cytotoxic action and molecular basis of resistance Oncogene 22 2003 7265 7279
7. M.B. Sporn, and N. Suh Chemoprevention of cancer Carcinogenesis 21 2000 525 530
8. A. Albini, F. Tosetti, V.W. Li, D.M. Noonan, and W.W. Li Cancer prevention by targeting angiogenesis Nat Rev Clin Oncol 9 2012 498 509
9. I. Appelmann, R. Liersch, T. Kessler, R.M. Mesters, and W.E. Berdel Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancy Recent Results Cancer Res 180 2010 51 81
10. G. Giannelli, and S. Antonaci MMP and TIMP assay in cancer. Biological and clinical significance Int J Cancer 116 2005 1002 1003
11. M.W. Roomi, J.C. Monterrey, T. Kalinovsky, M. Rath, and A. Niedzwiecki In vitro modulation of MMP-2 and MMP-9 in human cervical and ovarian cancer cell lines by cytokines, inducers and inhibitors Oncol Rep 23 2010 605 614
12. L.A. Tibbles, and J.R. Woodgett The stress-activated protein kinase pathways Cell Mol Life Sci 55 1999 1230 1254
13. S.S. Husain, I.L. Szabo, R. Pai, B. Soreghan, M.K. Jones, and A.S. Tarnawski MAPK (ERK2) kinase-a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth Life Sci 69 2001 3045 3054
14. B. El Mchichi, A. Hadji, A. Vazquez, and G. Leca p38 MAPK and MSK1 mediate caspase-8 activation in manganese-induced mitochondria-dependent cell death Cell Death Differ 14 2007 1826 1836
15. C.A. Taylor, Q. Zheng, Z. Liu, and J.E. Thompson Role of p38 and JNK MAPK signaling pathways and tumor suppressor p53 on induction of apoptosis in response to Ad-eIF5A1 in A549 lung cancer cells Mol Cancer 12 2013 35
16. S. Mandlekar, and A.N. Kong Mechanisms of tamoxifen-induced apoptosis Apoptosis 6 2001 469 477
17. J.M. Olson, and A.R. Hallahan p38 MAP kinase: a convergence point in cancer therapy Trends Mol Med 10 2004 125 129
18. C.J. Weng, and G.C. Yen Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities Cancer Metastasis Rev 31 2012 323 351
19. P.N. Chen, W.H. Kuo, C.L. Chiang, H.L. Chiou, Y.S. Hsieh, and S.C. Chu Black rice anthocyanins inhibit cancer cells invasion via repressions of MMPs and u-PA expression Chem Biol Interact 163 2006 218 229
20. J. Czyz, Z. Madeja, U. Irmer, W. Korohoda, and D.F. Hülser Flavonoid apigenin inhibits motility and invasiveness of carcinoma cells in vitro Int J Cancer 114 2005 12 18
21. F.L. Zhang, W. Zhang, X.M. Chen, and R.Y. Luo Effects of quercetin and quercetin in combination with cisplatin on adhesion, migration and invasion of HeLa cells Zhonghua Fu Chan Ke Za Zhi 43 2008 619 621
22. Y.J. Chen, N. Kay, J.M. Yang, C.T. Lin, H.L. Chang, and Y.C. Wu Total synthetic protoapigenone WYC02 inhibits cervical cancer cell proliferation and tumour growth through PIK3 signalling pathway Basic Clin Pharmacol Toxicol 113 2013 8 18
23. H.M. Chen, F.R. Chang, Y.C. Hsieh, Y.J. Cheng, K.C. Hsieh, and L.M. Tsai A novel synthetic protoapigenone analogue, WYC02-9, induces DNA damage and apoptosis in DU145 prostate cancer cells through generation of reactive oxygen species Free Radic Biol Med 50 2011 1151 1162
24. Y.J. Chen, H.P. Chen, Y.J. Cheng, Y.H. Lin, K.W. Liu, and Y.J. Chen The synthetic flavonoid WYC02-9 inhibits colorectal cancer cell growth through ROS-mediated activation of MAPK14 pathway Life Sci 92 2013 1081 1092
25. A.S. Lin, F.R. Chang, C.C. Wu, C.C. Liaw, and Y.C. Wu New cytotoxic flavonoids from Thelypteris torresiana Planta Med 71 2005 867 870
26. A.S. Lin, K. Nakagawa-Goto, F.R. Chang, D. Yu, S.L. Morris-Natschke, and C.C. Wu First total synthesis of protoapigenone and its analogues as potent cytotoxic agents J Med Chem 50 2007 3921 3927
27. S.S. Yuan, M.F. Hou, Y.C. Hsieh, C.Y. Huang, Y.C. Lee, and Y.J. Chen Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer J Natl Cancer Inst 104 2012 1485 1502
28. H.L. Chang, Y.C. Wu, J.H. Su, Y.T. Yeh, and S.S. Yuan Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2 J Pharmacol Exp Ther 325 2008 841 849
29. F.C. Ke, L.C. Chuang, M.T. Lee, Y.J. Chen, S.W. Lin, and P.S. Wang The modulatory role of transforming growth factor beta1 and androstenedione on follicle-stimulating hormone-induced gelatinase secretion and steroidogenesis in rat granulosa cells Biol Reprod 70 2004 1292 1298
30. Y.T. Yeh, F. Ou-Yang, I.F. Chen, S.F. Yang, Y.Y. Wang, and H.Y. Chuang STAT3 ser727 phosphorylation and its association with negative estrogen receptor status in breast infiltrating ductal carcinoma Int J Cancer 118 2006 2943 2947
31. N. Weidner Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors Breast Cancer Res Treat 36 1995 169 180
32. A.C. Brown, C. Shah, J. Liu, J.T. Pham, J.G. Zhang, and M.R. Jadus Ginger's (Zingiber officinale Roscoe) inhibition of rat colonic adenocarcinoma cells proliferation and angiogenesis in vitro Phytother Res 23 2009 640 645
33. C.C. Park, J.C. Morel, M.A. Amin, M.A. Connors, L.A. Harlow, and A.E. Koch Evidence of IL-18 as a novel angiogenic mediator J Immunol 167 2001 1644 1653
34. M. Westerfield The zebrafish book: a guide for the laboratory use of zebrafish 1993 The University of Oregon Press Eugene, Oregon
35. G.N. Serbedzija, E. Flynn, and C.E. Willett Zebrafish angiogenesis: a new model for drug screening Angiogenesis 3 1999 353 359
36. K. Issbrücker, H.H. Marti, S. Hippenstiel, G. Springmann, R. Voswinckel, and A. Gaumann p38 MAP kinase-a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability FASEB J 17 2003 262 264
37. H. Yin, Z. Liu, F. Li, M. Ni, B. Wang, and Y. Qiao Ginsenoside-Rg1 enhances angiogenesis and ameliorates ventricular remodeling in a rat model of myocardial infarction J Mol Med (Berl) 89 2011 363 375
38. A. Denley, M. Gymnopoulos, S. Kang, C. Mitchell, and P.K. Vogt Requirement of phosphatidylinositol(3,4,5)trisphosphate in phosphatidylinositol 3-kinase-induced oncogenic transformation Mol Cancer Res 7 2009 1132 1138
39. J.K. Schwarz, J.E. Payton, R. Rashmi, T. Xiang, Y. Jia, and P. Huettner Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer Clin Cancer Res 18 2012 1464 1471
40. Y.C. Lim, H.Y. Park, H.S. Hwang, S.U. Kang, J.H. Pyun, and M.H. Lee (-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells Cancer Lett 271 2008 140 152
41. I.A. Siddiqui, A. Malik, V.M. Adhami, M. Asim, B.B. Hafeez, and S. Sarfaraz Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAILmediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis Oncogene 27 2008 2055 2063
42. P.K. Vayalil, and S.K. Katiyar Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and-9 via inhibition of activation of mitogen-activated protein kinases, c-Jun and NF-kappaB in human prostate carcinoma DU-145 cells Prostate 59 2004 33 42
43. Y. Sato Aminopeptidases and angiogenesis Endothelium 10 2003 287 290
44. A. Pircher, W. Hilbe, I. Heidegger, J. Drevs, A. Tichelli, and M. Medinger Biomarkers in tumor angiogenesis and anti-angiogenic therapy Int J Mol Sci 12 2011 7077 7099
45. D.H. Gorski, M.A. Beckett, N.T. Jaskowiak, D.P. Calvin, H.J. Mauceri, and R.M. Salloum Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation Cancer Res 59 1999 3374 3378
46. F.A. Scappaticci Mechanisms and future directions for angiogenesis based cancer therapies J Clin Oncol 18 2002 3906 3927